Baxter International (BAX) Revenue (2009 - 2026)

Baxter International (BAX) has 18 years of Revenue data on file, last reported at $2.7 billion in Q1 2026.

• Revenue for Q1 2026 came in at $2.7 billion, up 2.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.8 billion (changed 0.06% YoY), and the FY2025 annual result was $11.2 billion, up 5.72% from the prior year.
• Revenue advanced to $2.7 billion in Q1 2026 per BAX's latest filing, from $2.6 billion in the prior quarter.
• Over five years, Revenue peaked at $3.7 billion in Q4 2022 and troughed at $2.4 billion in Q1 2023.
• A 5-year average of $2.9 billion and a median of $2.7 billion in 2024 frame the typical range for Revenue.
• The sharpest annual moves came in 2022 and 2023: Revenue soared 30.22% in 2022, then tumbled 31.39% in 2023.
• A 5-year view of Revenue shows it stood at $3.7 billion in 2022, then declined by 27.13% to $2.7 billion in 2023, then climbed by 0.88% to $2.8 billion in 2024, then fell by 4.65% to $2.6 billion in 2025, then increased by 2.9% to $2.7 billion in 2026.
• Business Quant data shows BAX's Revenue at $2.7 billion in Q1 2026, $2.6 billion in Q1 2025, and $2.8 billion in Q4 2024.